Davids Biotechnologie GmbH
Biotechnology
-
Short facts
-
- Research & Development
- Service Provider
- Year founded 1996
- 8 Employees (site)
- Turnover: <5m EUR
Products/services: Polyclonal and monoclonal Antibody Production in Germany with high standards and animal friendly methods since 1996. Immunization of rabbits, chicken, mice, rats and guineapigs with antigens provided by customer or synthesized by Davids. Purification of cell culture supernatants and antisera. Development of monoclonal antibodies and Production & Purification of IgG, IgM and other antibodies.
Basic data
Company
Davids Biotechnologie GmbH
Street
Röntgenstr. 3
PC / City
93055 Regensburg
County
Upper Palatinate
Phone
+49 941 948228
Fax
+49 941 9468119
Homepage
Language skills
English, German
Contact person
Management, Sales / marketing, Research & development: Dr. Timo Davids (Mr.)
Profile/competences
Core competencies
Antibody Production, Antibody Service, Antibody Purification, Polyclonal antibodies, monoclonal antibodies, Fab fragments, fluorescent dye labelling, enzyme conjugations, transient transfection, protein purification, In Vitro diagnostics; Chromatographic Procedures; ; Antibody Technology; Antigen Technology; Hybridome Production, Antibody purification, Antibody modifications. Theranostics; Cell based assays; Personalized Medicine, natural killer cell assay, in vitro cytotoxicity test.
Key sectors / sub-sectors
- Biotechnology: Tissue engineering and regenerative medicine
NACE industries
- Scientific research and development 72
- Human health activities 86
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States, Venezuela
Cooperation offers
not available